Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03372902 · ClinicalTrials.gov registry record
Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 628
- Enrollment target
NCT03372902: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03372902 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 628 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03372902 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 628 participants
- Enrollment target
Study Summary
The purpose of this study is to collect blood and tissue to help develop tests that might be able to detect cancer earlier. The investigator will be collecting these samples and reviewing test results from participants who have had an area of concern found on breast imaging, as well as from participants who are scheduled to have a routine breast cancer screening mammogram.
Interventions
- OTHER Blood draw
- DEVICE Breast MRI
- DEVICE Breast Mammogram
- PROCEDURE Breast Biopsy
- BEHAVIORAL online participant reported questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 628 participants |
| Start Date | 2017-12-07 |
| Est. Completion | 2025-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03372902
The ClinicalTrials.gov registry entry for NCT03372902 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 628 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Blood draw is the first listed.
NCT03372902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03372902 about?
NCT03372902 is a clinical study titled "Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening". The purpose of this study is to collect blood and tissue to help develop tests that might be able to detect cancer earlier. The investigator will be collecting these samples and reviewing test results from participants who have had an area of concern found on breast imaging, as well as from particip...
What is the current status of trial NCT03372902?
This trial is currently completed. The enrollment target is 628 participants. The study started on 2017-12-07. Estimated completion is 2025-03-12.
What interventions are being tested in trial NCT03372902?
The interventions under investigation include: Blood draw (OTHER), Breast MRI (DEVICE), Breast Mammogram (DEVICE), Breast Biopsy (PROCEDURE), online participant reported questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT03372902?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.